<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of <z:hpo ids='HP_0011900'>hypofibrinogenemia</z:hpo> caused by heterozygosity for gamma Ala82Gly in a 69-year-old Polish woman with severe <z:hpo ids='HP_0001892'>bleeding tendency</z:hpo> and a history of six <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>She suffered from frequent mucocutaneous <z:mp ids='MP_0001914'>bleedings</z:mp>, epistaxes requiring therapeutic interventions, prolonged <z:mp ids='MP_0001914'>bleedings</z:mp> after tooth extractions and surgical interventions </plain></SENT>
<SENT sid="2" pm="."><plain>Her mother and sister had <z:hpo ids='HP_0001892'>bleeding tendency</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Fibrinogen levels ranged from 0.93 to 2.0 g/l (von Clauss method) </plain></SENT>
<SENT sid="4" pm="."><plain>Fibrinogen antigen levels determined by immunonephelometry were about 2 g/l </plain></SENT>
<SENT sid="5" pm="."><plain>No other coagulation, platelet or liver function tests yielded abnormal results </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> was excluded </plain></SENT>
<SENT sid="7" pm="."><plain>This report suggests that the fibrinogen gamma Ala82Gly mutation could have variable clinical presentation </plain></SENT>
</text></document>